Cargando…
Potential Antiviral Options against SARS-CoV-2 Infection
As of June 2020, the number of people infected with severe acute respiratory coronavirus 2 (SARS-CoV-2) continues to skyrocket, with more than 6.7 million cases worldwide. Both the World Health Organization (WHO) and United Nations (UN) has highlighted the need for better control of SARS-CoV-2 infec...
Autores principales: | Ianevski, Aleksandr, Yao, Rouan, Fenstad, Mona Høysæter, Biza, Svetlana, Zusinaite, Eva, Reisberg, Tuuli, Lysvand, Hilde, Løseth, Kirsti, Landsem, Veslemøy Malm, Malmring, Janne Fossum, Oksenych, Valentyn, Erlandsen, Sten Even, Aas, Per Arne, Hagen, Lars, Pettersen, Caroline H., Tenson, Tanel, Afset, Jan Egil, Nordbø, Svein Arne, Bjørås, Magnar, Kainov, Denis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354438/ https://www.ncbi.nlm.nih.gov/pubmed/32545799 http://dx.doi.org/10.3390/v12060642 |
Ejemplares similares
-
Active Components of Commonly Prescribed Medicines Affect Influenza A Virus–Host Cell Interaction: A Pilot Study
por: Ianevski, Aleksandr, et al.
Publicado: (2021) -
Identification and Tracking of Antiviral Drug Combinations
por: Ianevski, Aleksandr, et al.
Publicado: (2020) -
Nafamostat–Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2
por: Ianevski, Aleksandr, et al.
Publicado: (2021) -
Novel Synergistic Anti-Enteroviral Drug Combinations
por: Ianevski, Aleksandr, et al.
Publicado: (2022) -
Seven classes of antiviral agents
por: Ianevski, Aleksandr, et al.
Publicado: (2022)